List of Excipients in API nateglinide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing nateglinide
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | CELLULOSE, MICROCRYSTALLINE | |
Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | CROSCARMELLOSE SODIUM | |
Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | FERRIC OXIDE RED | |
Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | HYPROMELLOSE 2208 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing nateglinide
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 | FD&C RED NO. 40 |
Actavis Pharma Inc | nateglinide | 0591-3354 | FERRIC OXIDE RED |
Actavis Pharma Inc | nateglinide | 0591-3354 | FERROSOFERRIC OXIDE |
Actavis Pharma Inc | nateglinide | 0591-3354 | FUMARIC ACID |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for nateglinide
Excipient focus: ANHYDROUS CITRIC ACID
nateglinide drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
Zydus Lifesciences Limited | nateglinide | 70771-1015 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
nateglinide drug variants containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
nateglinide drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
Par Pharmaceutical Inc | nateglinide | 49884-984 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
>Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
nateglinide drug variants containing COLLOIDAL SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | nateglinide | 54868-6255 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing COLLOIDAL SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE
nateglinide drug variants containing COPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing COPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
nateglinide drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
Par Pharmaceutical Inc | nateglinide | 49884-984 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
nateglinide drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
Zydus Lifesciences Limited | nateglinide | 70771-1015 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
nateglinide drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
nateglinide drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | nateglinide | 54868-6255 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
nateglinide drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
AvKARE | nateglinide | 42291-636 |
Par Pharmaceutical Inc | nateglinide | 49884-984 |
Golden State Medical Supply Inc | nateglinide | 51407-656 |
Physicians Total Care Inc | nateglinide | 54868-6255 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
nateglinide drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: FUMARIC ACID
nateglinide drug variants containing FUMARIC ACID
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing FUMARIC ACID
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
nateglinide drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Nivagen Pharmaceuticals Inc | nateglinide | 75834-205 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
nateglinide drug variants containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
nateglinide drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
nateglinide drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
Zydus Lifesciences Limited | nateglinide | 70771-1015 |
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
Modavar Pharmaceuticals LLC | nateglinide | 72241-002 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
nateglinide drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nateglinide drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
nateglinide drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
nateglinide drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
Par Pharmaceutical Inc | nateglinide | 49884-984 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Physicians Total Care Inc | nateglinide | 54868-6255 |
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
nateglinide drug variants containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
Modavar Pharmaceuticals LLC | nateglinide | 72241-002 |
Nivagen Pharmaceuticals Inc | nateglinide | 75834-205 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
nateglinide drug variants containing POLYETHYLENE GLYCOLS
Company | Ingredient | NDC |
---|---|---|
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing POLYETHYLENE GLYCOLS
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
nateglinide drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
Zydus Lifesciences Limited | nateglinide | 70771-1015 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
nateglinide drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
Par Pharmaceutical Inc | nateglinide | 49884-984 |
Golden State Medical Supply Inc | nateglinide | 51407-656 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
nateglinide drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
AvKARE | nateglinide | 42291-636 |
Par Pharmaceutical Inc | nateglinide | 49884-984 |
Golden State Medical Supply Inc | nateglinide | 51407-656 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K12
nateglinide drug variants containing POVIDONE K12
Company | Ingredient | NDC |
---|---|---|
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing POVIDONE K12
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
nateglinide drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
Modavar Pharmaceuticals LLC | nateglinide | 72241-002 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
nateglinide drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | nateglinide | 54868-6255 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
nateglinide drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
Modavar Pharmaceuticals LLC | nateglinide | 72241-002 |
Nivagen Pharmaceuticals Inc | nateglinide | 75834-205 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
nateglinide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
Par Pharmaceutical Inc | nateglinide | 49884-984 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
nateglinide drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
nateglinide drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
AvKARE | nateglinide | 42291-636 |
Par Pharmaceutical Inc | nateglinide | 49884-984 |
Golden State Medical Supply Inc | nateglinide | 51407-656 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
nateglinide drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
AvKARE | nateglinide | 42291-636 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | nateglinide | 0591-3354 |
Physicians Total Care Inc | nateglinide | 54868-6255 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
nateglinide drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
Actavis Pharma Inc | nateglinide | 0591-3354 |
NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
>Company | >Ingredient | >NDC |
nateglinide drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | nateglinide | 54868-6255 |
Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.